Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Dec 12, 2025 · Filed Dec 16, 2025
A board member of Globus Medical sold $355K of Globus Medical shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$355,400
Shares × reported transaction price
36 days after results of Nov 6, 2025, 26 days before results of Jan 7, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.0% | +2.8% | +1.1% |
| 30 days | +9.9% | +3.0% | +6.9% |
| 90 days | +3.6% | −0.1% | +3.7% |
| 180 days | −9.1% | +12.4% | −21.5% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
CFO sold ~$363K of Globus Medical
Scheduled in advance